Carmine Therapeutics to Present at Biotech Showcase™ 2023
Cambridge, MA/January 5, 2023 – Carmine Therapeutics, today announced that it is presenting at Biotech Showcase™ 2023. This year, registered attendees can view Carmine’s presentation live, and also access a recorded version beginning November 29th – SIX weeks prior to the actual event. With 24×7 on-demand access, attendees can view recorded presentations at their convenience when scheduling does not allow viewing during the main event week.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Carmine’s REGENT® gene therapy delivery platform offers several competitive advantages over both AAV and LNP, including safety, tolerability, expression, durability, and applicability.
- The ability to redose Carmine’s RBCEVs, as well as the flexibility to include multiple payloads beyond the capacity of AAV, while targeting many tropisms, opens the door to the use of gene therapy to target diseases not previously addressable by first- and second-generation approaches.
- Carmine is led by industry veterans with decades of experience in the gene and cell therapy market, along with a world renowned scientific advisory and board of directors.
Click image above to view full announcement.
Carmine Therapeutics was founded in 2019 by EVX Ventures, Professor Harvey Lodish (Whitehead, MIT) and Singaporean Professors Minh Le and Jiahai Shi. Professor Lodish, who was a founding member of several successful biotech companies that include Genzyme, Arris (now Axys) Pharmaceuticals, Millennium Pharmaceuticals and Rubius Therapeutics, is also Chair of the Scientific Advisory Board of Carmine. Headquartered in Cambridge, MA with a research presence in Singapore, Carmine is pioneering next generation gene therapy based on red blood cell extracellular vesicles.
About Biotech Showcase
Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 15th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
Source: Carmine Therapeutics
Distributed by: Reportable, Inc.
Source: Financial Content
